Sociedad Americana de Hirudoterapia

Pharmacy and Poisons Board

PPB · Kenya · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Kenya's Pharmacy and Poisons Board — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national medical device framework or traditional medicine pathways as appropriate.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Kenya
Leech status
unregulated
Last ASH review
2026-05-26

Relevant Regulation Codes

  • Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya
  • Kenyan framework for traditional and alternative medicine practice as appropriate

Prescriber Requirements

  • Kenya Medical Practitioners and Dentists Council–registered physician — order required for any biomedical device application
  • Traditional health practitioners registered under Kenyan national law may have separate scope; specific hirudotherapy authorisation not independently verified by ASH

Supply Chain & GMP

PPB registration as applicable; English and Kiswahili-language labelling. Standard cold-chain conditions.

Import/Export Rules

PPB import authorisation; Directorate of Veterinary Services clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Not covered under public insurance schemes for leech therapy specifically.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Kenya is moving toward an enhanced medical-device regulatory framework; whether hirudotherapy is being captured by these reforms has not been independently mapped by ASH.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.